Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Orsel, Kim"'
Autor:
Orsel, Kim, Taipale, Heidi, Tolppanen, Anna-Maija, Koponen, Marjaana, Tanskanen, Antti, Tiihonen, Jari, Gardarsdottir, Helga, Hartikainen, Sirpa
Publikováno v:
In European Neuropsychopharmacology November 2018 28(11):1260-1269
Autor:
Orsel, Kim, Taipale, Heidi, Raatikainen, Sami, Lampela, Pasi, Tolppanen, Anna-Maija, Koponen, Marjaana, Tanskanen, Antti, Tiihonen, Jari, Gardarsdottir, Helga, Hartikainen, Sirpa, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Clinical Psychopharmacology, 38(5), 494. Lippincott Williams and Wilkins
Background Antipsychotics (APs) are known to exacerbate symptoms of benign prostate hyperplasia (BPH) and may even cause urinary retention. The anticholinergic effects of APs and their dopamine D2- and α-receptor blockade may lead to voiding dysfunc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b753feed88dfa1e34b344e5567356c5
https://dspace.library.uu.nl/handle/1874/369789
https://dspace.library.uu.nl/handle/1874/369789
Autor:
Orsel, Kim, Taipale, Heidi, Tolppanen, Anna-Maija, Koponen, Marjaana, Tanskanen, Antti, Tiihonen, Jari, Gardarsdottir, Helga, Hartikainen, Sirpa, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Neuropsychopharmacology, 28(11), 1260. Elsevier
Psychotropic drugs are frequently used for the treatment of behavioural and psychological symptoms of dementia in persons with Alzheimer's disease (AD). Evidence for benefits are limited and concerns have been raised about the safety, especially for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8c6b7b813916c55741ebd92bd9ffb3
https://pubmed.ncbi.nlm.nih.gov/30153953
https://pubmed.ncbi.nlm.nih.gov/30153953
Autor:
Orsel K, Taipale H, Raatikainen S; Department of Urology, Kuopio University Hospital., Lampela P, Tolppanen AM; School of Pharmacy and., Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2018 Oct; Vol. 38 (5), pp. 494-497.